Pharmalot reports that a clinical trial for a pneumonia vaccine in Argentina by GlaxoSmithKline has resulted in the death of twelve infants. There were 15,000 infants who participated in this trial. The article states that the majority of the participants came from underprivileged familes, who could not read the consent form at the time of the agreement. Pneumonia is the leading cause of death in infants from infectious diseases and results in the death of two million children around the world under the age of five.
GlaxoSmithKline pointed out: the infant post-neonatal mortality rate of children participating in the COMPAS study does not exceed the post-neonatal mortality rate in the countries participating in the study.
No comments:
Post a Comment